8 USD
+0.17 (+2.17%)
8.1026 USD
+0.1 (+1.28%)
ChartMill assigns a Buy % Consensus number of 84% to RLAY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.18. This target is 77.23% above the current price.
RLAY was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RLAY.
In the previous month the buy percentage consensus was at a similar level.
RLAY was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-05-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-04-17 | Wells Fargo | Initiate | Equal-Weight |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-27 | Stifel | Maintains | Buy -> Buy |
| 2025-02-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-12 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-04 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-12-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-17 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-16 | Stifel | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-10 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-09-10 | Barclays | Maintains | Overweight -> Overweight |
| 2024-09-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-09-10 | Goldman Sachs | Reiterate | Buy |
| 2024-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-10 | Jefferies | Upgrade | Hold -> Buy |
| 2024-08-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-07-26 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-18 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-10 | Barclays | Upgrade | Equal-Weight -> Overweight |
RELAY THERAPEUTICS INC / RLAY FAQ
What do analysts expect the price target to be for RELAY THERAPEUTICS INC (RLAY)?
18 analysts have analysed RLAY and the average price target is 14.18 USD. This implies a price increase of 77.23% is expected in the next year compared to the current price of 8.
How do analysts rate RELAY THERAPEUTICS INC (RLAY)?
The consensus rating for RELAY THERAPEUTICS INC (RLAY) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover RELAY THERAPEUTICS INC (RLAY) stock?
The number of analysts covering RELAY THERAPEUTICS INC (RLAY) is 18.